148 related articles for article (PubMed ID: 34703395)
1. Evaluation of
Boddeti DK; Kumar V
World J Nucl Med; 2021; 20(3):266-272. PubMed ID: 34703395
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging.
Ebenhan T; Zeevaart JR; Venter JD; Govender T; Kruger GH; Jarvis NV; Sathekge MM
J Nucl Med; 2014 Feb; 55(2):308-14. PubMed ID: 24434293
[TBL] [Abstract][Full Text] [Related]
3. Imaging of bacterial infection: Harnessing positron emission tomography and Cherenkov luminescence imaging with UBI-derived octapeptide.
Mitra JB; Mukherjee A; Kumar A; Chandak A; Rakshit S; Yadav HD; Pandey BN; Sarma HD
Drug Dev Res; 2023 Nov; 84(7):1513-1521. PubMed ID: 37571805
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection.
Akhtar MS; Iqbal J; Khan MA; Irfanullah J; Jehangir M; Khan B; Ul-Haq I; Muhammad G; Nadeem MA; Afzal MS; Imran MB
J Nucl Med; 2004 May; 45(5):849-56. PubMed ID: 15136636
[TBL] [Abstract][Full Text] [Related]
5. ⁶⁸Ga-NOTA-UBI-29-41 as a PET Tracer for Detection of Bacterial Infection.
Vilche M; Reyes AL; Vasilskis E; Oliver P; Balter H; Engler H
J Nucl Med; 2016 Apr; 57(4):622-7. PubMed ID: 26769861
[TBL] [Abstract][Full Text] [Related]
6. (68)Ga-radiopharmaceuticals for PET imaging of infection and inflammation.
Kumar V; Boddeti DK
Recent Results Cancer Res; 2013; 194():189-219. PubMed ID: 22918761
[TBL] [Abstract][Full Text] [Related]
7. Potential use of 68Ga-apo-transferrin as a PET imaging agent for detecting Staphylococcus aureus infection.
Kumar V; Boddeti DK; Evans SG; Roesch F; Howman-Giles R
Nucl Med Biol; 2011 Apr; 38(3):393-8. PubMed ID: 21492788
[TBL] [Abstract][Full Text] [Related]
8. Gallium-68 labeled Ubiquicidin derived octapeptide as a potential infection imaging agent.
Bhatt J; Mukherjee A; Shinto A; Koramadai Karuppusamy K; Korde A; Kumar M; Sarma HD; Repaka K; Dash A
Nucl Med Biol; 2018; 62-63():47-53. PubMed ID: 29883883
[TBL] [Abstract][Full Text] [Related]
9.
Ebenhan T; Sathekge MM; Lengana T; Koole M; Gheysens O; Govender T; Zeevaart JR
J Nucl Med; 2018 Feb; 59(2):334-339. PubMed ID: 29051342
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the potential of kit-based 68Ga-ubiquicidin formulation in diagnosis of infection: a pilot study68Ga.
Bhusari P; Bhatt J; Sood A; Kaur R; Vatsa R; Rastogi A; Mukherjee A; Dash A; Mittal BR; Shukla J
Nucl Med Commun; 2019 Mar; 40(3):228-234. PubMed ID: 30480552
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of potential infection-imaging probe [
Nielsen KM; Jørgensen NP; Kyneb MH; Borghammer P; Meyer RL; Thomsen TR; Bender D; Jensen SB; Nielsen OL; Alstrup AKO
J Labelled Comp Radiopharm; 2018 May; ():. PubMed ID: 29790580
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results of biodistribution and dosimetric analysis of [
Khawar A; Eppard E; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
Ann Nucl Med; 2019 Jun; 33(6):404-413. PubMed ID: 30877560
[TBL] [Abstract][Full Text] [Related]
14. Peptide synthesis, characterization and ⁶⁸Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET/CT.
Ebenhan T; Chadwick N; Sathekge MM; Govender P; Govender T; Kruger HG; Marjanovic-Painter B; Zeevaart JR
Nucl Med Biol; 2014; 41(5):390-400. PubMed ID: 24630816
[TBL] [Abstract][Full Text] [Related]
15. Biokinetics of (99m)Tc-UBI 29-41 in humans.
Meléndez-Alafort L; Rodríguez-Cortés J; Ferro-Flores G; Arteaga De Murphy C; Herrera-Rodríguez R; Mitsoura E; Martínez-Duncker C
Nucl Med Biol; 2004 Apr; 31(3):373-9. PubMed ID: 15028250
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Assessment of a
Ebenhan T; Mokaleng BB; Venter JD; Kruger HG; Zeevaart JR; Sathekge M
Molecules; 2017 Aug; 22(9):. PubMed ID: 28837117
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of antimicrobial peptide [(99m)Tc/Tricine/HYNIC(0)]ubiquicidin 29-41 as a human-specific infection imaging agent.
Gandomkar M; Najafi R; Shafiei M; Mazidi M; Goudarzi M; Mirfallah SH; Ebrahimi F; Heydarpor HR; Abdie N
Nucl Med Biol; 2009 Feb; 36(2):199-205. PubMed ID: 19217532
[TBL] [Abstract][Full Text] [Related]
18. (68)Ga-Citrate-PET for diagnostic imaging of infection in rats and for intra-abdominal infection in a patient.
Kumar V; Boddeti DK; Evans SG; Angelides S
Curr Radiopharm; 2012 Jan; 5(1):71-5. PubMed ID: 22074481
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial.
Akhtar MS; Qaisar A; Irfanullah J; Iqbal J; Khan B; Jehangir M; Nadeem MA; Khan MA; Afzal MS; Ul-Haq I; Imran MB
J Nucl Med; 2005 Apr; 46(4):567-73. PubMed ID: 15809477
[TBL] [Abstract][Full Text] [Related]
20.
Mukherjee A; Bhatt J; Shinto A; Korde A; Kumar M; Kamaleshwaran K; Joseph J; Sarma HD; Dash A
J Pharm Biomed Anal; 2018 Sep; 159():245-251. PubMed ID: 29990892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
